Physician profile
John D Curtis
NPI 1487622031
$7,375.25
in general payments reported to CMS, 2019-2025
34 companies · $771 in 2025
The $771 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $16.42 · 2021: $3,580 · 2022: $295 · 2023: $2,097 · 2024: $321 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,800 · Food and Beverage: $1,193 · Travel and Lodging: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,800.00 |
| Food and Beverage | $1,193.37 |
| Travel and Lodging | $195.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,062.83 | 2021-2023 | Distal Extremities Implants Trauma |
| Encore Medical, LP | $2,337.01 | 2021-2023 | Djo Surgical |
| Ortho Development Corporation | $276.76 | 2025 | |
| Depuy Synthes Sales INC. | $197.33 | 2022-2025 | Na, Intrafix, Dynatape |
| Smith+Nephew, INC. | $165.40 | 2022-2023 | Legion Revision, Real Intelligence, Journey II |
| Prime Surgical, LLC | $124.17 | 2019 | |
| Pfizer INC. | $106.02 | 2019-2024 | |
| US Implant Solutions, LLC | $104.50 | 2025 | |
| Ethicon US, LLC | $103.67 | 2022-2025 | Stratafix, Surgiflo Hemostatic Matrix, Vistaseal |
| Pacira Therapeutics, INC. | $103.64 | 2019-2021 | |
| Amgen INC. | $101.75 | 2024-2025 | Krystexxa |
| Bioventus LLC | $91.07 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Carbofix Orthopedics INC | $85.07 | 2021-2022 | |
| Acera Surgical, INC. | $44.92 | 2019 | |
| Convatec INC. | $44.65 | 2022-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $43.77 | 2023 | Seglentis |
| Exactech, INC. | $33.29 | 2025 | |
| Biocomposites INC | $29.58 | 2025 | Stimulan |
| Ermi LLC | $27.37 | 2019-2025 | |
| Radius Health, INC. | $26.95 | 2025 | Tymlos |
| Molnlycke Health Care US, LLC | $25.70 | 2025 | Mepilex Border Post-Op Ag, Avance |
| Kinex Medical Company LLC | $25.50 | 2025 | Kinex Connect |
| Orthofix Medical, INC. | $22.44 | 2024 | Cervical-Stim |
| Vertex Pharmaceuticals Incorporated | $21.71 | 2025 | |
| Heron Therapeutics, INC. | $20.26 | 2021 | |
| Illuminoss Medical, INC. | $20.08 | 2024 | |
| Zimmer Biomet Holdings, INC. | $19.53 | 2023 | Juggerstitch, Juggerknotless Soft Anchor, Tricera Handpiece |
| Solventum Corporation | $18.67 | 2024 | Prevena, V.A.C.Ulta |
| Heraeus Medical, LLC. | $17.23 | 2025 | |
| Atland Pharmaceuticals, LLC | $15.84 | 2025 | Tolmetin Sodium, Orphenadrine Citrate, Aspirin and Caffeine |
| Conmed Corporation | $15.81 | 2025 | Abc Handpieces |
| Spinal Simplicity, LLC | $15.16 | 2025 | Ha Minuteman G3-R |
| Abbott Laboratories | $13.86 | 2022 | |
| Orexo US, INC. | $13.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.